Increased plasma concentrations of cytoskeletal and Ca2+-binding proteins and their peptides in psoriasis patients.

BACKGROUND The mechanisms underlying psoriatic pathogenesis are not fully understood and might be elucidated by identifying novel disease-related molecular markers, including autoantigens. METHODS We used 2 proteomic methods to analyze plasma samples from 20 psoriasis patients and 20 matched healthy donors. The first method focused on evaluating changes in glycoprotein concentrations and the plasma proteome, and the second method assessed endogenous proteolytic activity by analyzing the low molecular weight component of plasma. RESULTS The integrated proteomic and peptidomic analysis identified a number of proteins and their fragments present at different concentrations in the plasma of psoriasis patients and healthy donors. We used ELISA to independently verify the changes in the concentrations of several of these proteins. One intriguing finding, increased concentrations of cytoskeletal and actin-binding proteins and their peptides in psoriatic plasma, suggested disease-related cell leakage of these proteins and their increased proteolysis. Among the increased proteins and peptides were thymosin beta 4, talin 1, actin gamma, filamin, and profilin. Increased concentrations of Ca(2+)-binding proteins calgranulins A and B in psoriatic plasma were also observed, confirming previous reports, and appeared to be relevant to the increase of cytoskeletal components. Another notable change in psoriatic plasma was a striking decrease in fibrinogen fragments. CONCLUSIONS The identified increased concentrations of cytoskeletal proteins, their peptides, and calgranulins in psoriatic plasma, as well as the underlying altered protease activity, are proposed to be related to psoriasis pathogenesis.

[1]  E. Diamandis,et al.  Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy , 2007, The British journal of dermatology.

[2]  H. Tammen,et al.  Peptidomic analysis of human blood specimens: Comparison between plasma specimens and serum by differential peptide display , 2005, Proteomics.

[3]  William S Hancock,et al.  Combination of abundant protein depletion and multi-lectin affinity chromatography (M-LAC) for plasma protein biomarker discovery. , 2007, Journal of proteome research.

[4]  A. Olshen,et al.  Differential exoprotease activities confer tumor-specific serum peptidome patterns. , 2005, The Journal of clinical investigation.

[5]  Chun-Ming Huang,et al.  In vivo detection of secreted proteins from wounded skin using capillary ultrafiltration probes and mass spectrometric proteomics , 2006, Proteomics.

[6]  M. Holick,et al.  Is psoriasis a T‐cell disease? , 2000, Experimental dermatology.

[7]  K. Smetana,et al.  Glycophenotype of psoriatic skin. , 2006, Folia biologica.

[8]  P. Tempst,et al.  Serum Peptidome Patterns That Distinguish Metastatic Thyroid Carcinoma from Cancer-free Controls Are Unbiased by Gender and Age*S , 2006, Molecular & Cellular Proteomics.

[9]  J. Guilhou,et al.  Primary hemostasis, platelet functions and coagulation in psoriasis. , 1989, Dermatologica.

[10]  A. Otto,et al.  Thymosin β4 is released from human blood platelets and attached by factor XIIIa (transglutaminase) to fibrin and collagen , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[11]  A. Bowcock The genetics of psoriasis and autoimmunity. , 2005, Annual review of genomics and human genetics.

[12]  Baruch S Blumberg,et al.  Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[13]  F. Nestle,et al.  Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities. , 2004, The Journal of clinical investigation.

[14]  L. Klareskog,et al.  Citrullinated proteins have increased immunogenicity and arthritogenicity and their presence in arthritic joints correlates with disease severity , 2005, Arthritis research & therapy.

[15]  M. Gürer,et al.  Caspase 9 is decreased in psoriatic epidermis. , 2006, Acta histochemica.

[16]  U. Mrowietz,et al.  Psoriasis scales contain C5a as the predominant chemotaxin for monocyte‐derived dendritic cells , 2001, Experimental dermatology.

[17]  A. Henschen-Edman Fibrinogen Non‐Inherited Heterogeneity and Its Relationship to Function in Health and Disease , 2001, Annals of the New York Academy of Sciences.

[18]  W. Hancock,et al.  Approach to the comprehensive analysis of glycoproteins isolated from human serum using a multi-lectin affinity column. , 2004, Journal of chromatography. A.

[19]  A. Hamsten,et al.  Psoriasis is associated with lipid abnormalities at the onset of skin disease. , 2006, Journal of the American Academy of Dermatology.

[20]  Identification of Peptide tumor markers in a tumor graft model in immunodeficient mice. , 2005, Combinatorial chemistry & high throughput screening.

[21]  E. Hannappel β‐Thymosins , 2007 .

[22]  James G. Krueger,et al.  Pathogenesis and therapy of psoriasis , 2007, Nature.

[23]  M. Vaccaro,et al.  Changes in the distribution of actin-associated proteins in psoriatic keratinocytes. Immunohistochemical study using confocal laser scanning microscopy , 1997, Archives of Dermatological Research.

[24]  E. Petricoin,et al.  The blood peptidome: a higher dimension of information content for cancer biomarker discovery , 2006, Nature Reviews Cancer.

[25]  S. Hanash,et al.  Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humoral immune response in lung cancer. , 2001, Cancer research.

[26]  A. Goldstein,et al.  Factor XIIIa incorporates thymosin beta4 preferentially into the fibrin(ogen) alphaC-domains. , 2004, Biochemistry.

[27]  H. Kleinman,et al.  Zyxin is upregulated in the nucleus by thymosin beta4 in SiHa cells. , 2006, Experimental cell research.

[28]  I. Stříž,et al.  Calprotectin - a pleiotropic molecule in acute and chronic inflammation. , 2004, Physiological research.

[29]  M. Pistis,et al.  Abnormalities of blood coagulation and fibrinolysis in psoriasis. , 1994, Dermatology.

[30]  E. Petricoin,et al.  Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold. , 2005, The Journal of clinical investigation.

[31]  J. Marx Thymosins: Clinical Promise After a Decades-Long Search , 2007, Science.

[32]  H. Yin,et al.  The β‐Thymosin Enigma , 2007 .

[33]  D. Srivastava,et al.  Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair , 2004, Nature.

[34]  W. Hancock,et al.  Analysis of the low molecular weight serum peptidome using ultrafiltration and a hybrid ion trap-Fourier transform mass spectrometer. , 2006, Journal of chromatography. A.

[35]  H. Kreipe,et al.  Peptidomic analysis of breast cancer reveals a putative surrogate marker for estrogen receptor-negative carcinomas , 2006, Laboratory Investigation.

[36]  H. Kleinman,et al.  Role of Thymosin β4 in Tumor Metastasis and Angiogenesis , 2003 .

[37]  S. Fleming,et al.  Calgranulin expression and association with the keratinocyte cytoskeleton , 1990, The Journal of pathology.

[38]  F. Teixeira,et al.  The inflammatory response in mild and in severe psoriasis , 2004, The British journal of dermatology.

[39]  D. Foell,et al.  Elevated serum levels of calcium‐binding S100 proteins A8 and A9 reflect disease activity and abnormal differentiation of keratinocytes in psoriasis , 2006, The British journal of dermatology.

[40]  A. Bowcock,et al.  Psoriasis: genetic associations and immune system changes , 2007, Genes and Immunity.